Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.31 |
| ▸ | UGCG | Q16739 | 4/20 | 0.30 |
| ▸ | GBA2 | Q9HCG7 | 4/20 | 0.30 |
| ▸ | GBA1 | P04062 | 3/20 | 0.30 |
| ▸ | LCT | P09848 | 3/20 | 0.30 |
| ▸ | MGAM | O43451 | 2/20 | 0.30 |
| ▸ | SI | P14410 | 2/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5341906 | 0.86 | SIGMAR1 (0.30) | SIGMAR1S1PR5S1PR1 | |
| SCHEMBL27550611 | 0.85 | KCNH2 (0.33) | S1PR5MEN1KMT2AS1PR1 | |
| SCHEMBL886987 | 0.83 | KMT2A (0.36) | MEN1KMT2A | |
| SCHEMBL4803323 | 0.83 | SIGMAR1 (0.31) | OPRM1OPRD1SIGMAR1MEN1KMT2A | |
| SCHEMBL27550619 | 0.83 | — | — | |
| SCHEMBL27570117 | 0.82 | CYP2D6 (0.33) | OPRM1S1PR5MEN1KMT2AS1PR1 | |
| SCHEMBL5336900 | 0.82 | BCHE (0.35) | OPRM1OPRD1S1PR5MEN1KMT2A | |
| SCHEMBL5340543 | 0.82 | CYP3A4 (0.34) | MAPTS1PR5MEN1KMT2AS1PR1 | |
| SCHEMBL5337585 | 0.82 | — | — | |
| SCHEMBL14590798 | 0.82 | BCHE (0.39) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10316114-B2 | End-functionalized polymers | BASF SE (DE) | 2019-06-11 | — | — | US | disclosed |
| EP-2552971-B1 | END-FUNCTIONALIZED POLYMERS | BASF SE (DE) | 2014-07-02 | — | — | EP | disclosed |
| US-8664324-B2 | Pigment dispersants with modified copolymers | BASF SE (DE) | 2014-03-04 | — | — | US | disclosed |
| US-8664324-B2 | Pigment dispersants with modified copolymers | BASF SE (DE) | 2014-03-04 | — | — | US | disclosed |
| US-8471031-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-06-25 | — | — | US | disclosed |
| US-8471031-B2 | Process for the preparation of sterically hindered nitroxyl ethers | BASF SE (DE) | 2013-06-25 | — | — | US | disclosed |
| US-20130030071-A1 | END-FUNCTIONALIZED POLYMERS | BASF SE (DE) | 2013-01-31 | — | — | US | disclosed |
| US-20130030071-A1 | END-FUNCTIONALIZED POLYMERS | BASF SE (DE) | 2013-01-31 | — | — | US | disclosed |
| EP-2247678-B1 | FLUORO LEVELLING AGENTS | BASF SE (DE) | 2011-11-30 | — | — | EP | disclosed |
| WO-2011120947-A1 | END-FUNCTIONALIZED POLYMERS | BASF SE (DE) | 2011-10-06 | — | — | WO | disclosed |
| EP-1436337-A1 | PROCESS FOR THE PREPARATION OF HYDROXY-VINYL-AROMATIC POLYMERS OR COPOLYMERS BY ANIONIC OR CONTROLLED RADICAL POLYMERIZATION | Ciba SC Holding AG (CH) | 2004-07-14 | — | — | EP | disclosed |
| US-6683142-B2 | PROVIDE POLYMERIC RESIN PRODUCTS HAVING LOW POLYDISPERSITY. | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-01-27 | — | — | US | disclosed |
| US-20030220423-A1 | 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators | KRAMER ANDREAS (CH) | 2003-11-27 | — | — | US | disclosed |
| US-6624306-B2 | Stabilizer for addition polymer | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-09-23 | — | — | US | disclosed |
| US-20030166939-A1 | 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides | NESVADBA PETER (CH) | 2003-09-04 | — | — | US | disclosed |
| US-6583245-B1 | Ethylenically unsaturated compound (acrylate or acrylamide) having sterically hindered amine, hydroxyphenyl triazine, hydroxyphenylbenzotriazole or a o-hydroxy-benzophenone group; a nitroxyl free radical initiator | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-06-24 | — | — | US | disclosed |
| US-20030065184-A1 | 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides | CIBA SPECIALTY CHEMICALS CORP. | 2003-04-03 | — | — | US | disclosed |
| WO-2003022895-A1 | PROCESS FOR THE PREPARATION OF HYDROXY-VINYL-AROMATIC POLYMERS OR COPOLYMERS BY ANIONIC OR CONTROLLED RADICAL POLYMERIZATION | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-03-20 | — | — | WO | disclosed |
| US-20020107397-A1 | 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators | KRAMER ANDREAS (CH) | 2002-08-08 | — | — | US | disclosed |
| US-6353107-B1 | FREE RADICAL CATALYSTS FOR ADDITION POLYMERIZATION; NARROW MOLECULAR WEIGHT DISTRIBUTION; HIGH PURITY AND COLORLESS | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166939-A1 | 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides | ALKBH2, NFE2L2, DPYSL2 | ALOX15 125/4885MAPT 3356/4885OPRM1 18/4885 |
| US-20020107397-A1 | 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators | CBR1, PYM1, ELOC | ALOX15 112/4885MAPT 4391/4885OPRM1 28/4885 |
| US-20030065184-A1 | 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides | ALKBH2, NFE2L2, DPYSL2 | ALOX15 125/4885MAPT 3356/4885OPRM1 18/4885 |
| US-20030220423-A1 | 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators | PYM1, ELOC, CBR1 | ALOX15 114/4885MAPT 4497/4885OPRM1 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.